Zhuoyan Li is an Oncology physician affiliated with Greater Baltimore Medical Center. OpenAlex indexes 28 publications with 448 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6535 N Charles St Ste 220
Baltimore, MD 212045823
Telephone
443-849-3051Provider last certified this registry record 8 Mar 2023.
Industry payments
41 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year202518 payments$11,186openpaymentsdata.cms.gov ↗
- E.R. Squibb & Sons, L.L.C.Program year20254 payments
- Takeda Pharmaceuticals U.S.A., Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
72.9%Aromatase Inhibitor32.1%Anastrozole66%Letrozole34%Part D≥53 patientsThalidomide Analog11.5%Lenalidomide71%Revlimid29%Part D<11 patients+ 5 more classes in this area
Blood & clotting
12.3%Factor Xa inhibitor12.3%Eliquis63%Xarelto37%Part D<11 patientsNervous system
6.4%Phenothiazine4.4%Prochlorperazine Maleate100%Part D≥21 patientsNonsteroidal Anti-inflammatory Drug2%Meloxicam100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Evolving dynamics of H5Nx avian influenza in China revealed by long-term wild bird surveillance
Nature Communications
2026 - Synergistic high-strength and high-toughness design of magnesium phosphate cement-based composites via carbon-fiber reinforcement
Construction and Building Materials
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Susan Aucott, MD
Greater Baltimore Medical Center
Janet Sunness, MD
Greater Baltimore Medical Center
Paul Celano, MD
Greater Baltimore Medical Center
Joan Blomquist, MD
Greater Baltimore Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”